Image
Kidney Disease
Topic Spotlight
An estimated 37 million people in the United States are affected by chronic kidney disease. (Centers for Disease Control and Prevention)
Approximately 33% (1 in 3) of adults with diabetes -- and 1 in 5 adults with high blood pressure -- may have chronic kidney disease. (Centers for Disease Control and Prevention)
PCORI has funded 24 comparative clinical effective research studies that aim to help patients and those who care for them make better-informed decisions about their treatment options for kidney disease. (As of February 2022)
Evidence for Decisions from PCORI-Funded Studies
Evidence Updates: Treating Depression in Patients with Kidney Failure Receiving Dialysis
More patients with kidney failure undergoing long-term hemodialysis who also had depression reported modest improvements in their depressive symptoms with the drug sertraline than patients receiving cognitive behavioral therapy, PCORI-funded researchers report in the Annals of Internal Medicine. However, patients who opted for the daily medication experienced greater adverse events, such as nausea and dizziness.
A pair of Evidence Updates is now available to help support conversations between patients and/or their caregivers and clinicians about treating depression while receiving maintenance hemodialysis.
Kidney Disease Study Spotlights
Kidney Transplants through Health System Change
This study is looking into whether a more proactive outreach program can help patients with kidney failure overcome roadblocks to receive transplants earlier in the course of disease.
Choosing Kidney Failure Treatments Early
This study is testing whether, compared with usual care, a patient-centered approach to transitional care improves outcomes for patients with kidney failure.
Extended Treatment of Blood Clots in People with Kidney Disease
Choosing drugs that prevent recurrence of deep-vein blood clots is challenging for people with impaired kidney function. This study compares the drugs’ benefits and risks over the long term.